Humacyte, Inc. ·
HUMA 8-K 2026-09-28
Humacyte, Inc. (HUMA) 8-K dated 2026-09-28 — accession 0001818382-26-000011.
Humacyte, Inc. (HUMA) common stock.
Humacyte, Inc. filed a 8-K on 2026-09-28. Accession 0001818382-26-000011.
This 8-K covers: Director/officer change (Item 5.02), Reg FD disclosure (Item 7.01), Exhibits (Item 9.01). SEC EDGAR holds the official filing and its exhibits.
Latest reported HUMA revenue for 2025-12-31 was $2.0M. Net income was -$40.8M. HUMA currently screens at market cap $139.2M.
Not investment advice. The HUMA SEC hub lists recent forms. The stock page is the research view.